SDAI Limited has signed a non-binding Memorandum of Understanding (MoU) with Hubei Qiai Group to establish a platform for bringing China’s mugwort products to global markets. This strategic move is set to capitalise on the growing popularity of mugwort, a traditional herb known for its soothing and aromatic qualities, which is gaining traction in wellness, beauty, and food industries worldwide.
Founded in 2021, Hubei Qiai has rapidly become a leader in China’s Traditional Chinese Medicine sector, focusing on the high-growth mugwort industry. The company operates across the entire value chain, from cultivation to distribution, and boasts a retail network of over 13,000 outlets across China. Hubei Qiai’s innovative approach includes transforming traditional moxibustion therapy into electric-based solutions, enhancing user experience and scalability.
The global mugwort market is projected to grow from $531.90m in 2025 to $798.75m by 2032, reflecting a compound annual growth rate of 5.94%. This partnership aims to tap into this expanding market, diversifying SDAI’s revenue streams and strengthening the international presence of mugwort products.
Executive Chairperson of SDAI, Hao Dongting, expressed enthusiasm about the collaboration, stating, “We are truly thrilled to partner with the leading name in the mugwort industry. This collaboration marks an exciting milestone as we expand into the fast-growing mugwort sector.”
As SDAI continues its transformation into a biotechnology company, this partnership with Hubei Qiai represents a significant step in its strategic expansion, potentially creating sustainable value for its shareholders.
